These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30659187)

  • 1. Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma.
    Lee C; Rudneva VA; Erkek S; Zapatka M; Chau LQ; Tacheva-Grigorova SK; Garancher A; Rusert JM; Aksoy O; Lea R; Mohammad HP; Wang J; Weiss WA; Grimes HL; Pfister SM; Northcott PA; Wechsler-Reya RJ
    Nat Commun; 2019 Jan; 10(1):332. PubMed ID: 30659187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma.
    Vo BT; Li C; Morgan MA; Theurillat I; Finkelstein D; Wright S; Hyle J; Smith SMC; Fan Y; Wang YD; Wu G; Orr BA; Northcott PA; Shilatifard A; Sherr CJ; Roussel MF
    Cell Rep; 2017 Mar; 18(12):2907-2917. PubMed ID: 28329683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe Inflammatory Reactions in Mice Expressing a GFI1
    Fraszczak J; Arman KM; Lacroix M; Vadnais C; Gaboury L; Möröy T
    J Immunol; 2021 Sep; 207(6):1599-1615. PubMed ID: 34408010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AML.
    Barth J; Abou-El-Ardat K; Dalic D; Kurrle N; Maier AM; Mohr S; Schütte J; Vassen L; Greve G; Schulz-Fincke J; Schmitt M; Tosic M; Metzger E; Bug G; Khandanpour C; Wagner SA; Lübbert M; Jung M; Serve H; Schüle R; Berg T
    Leukemia; 2019 Jun; 33(6):1411-1426. PubMed ID: 30679800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancer Activation by Pharmacologic Displacement of LSD1 from GFI1 Induces Differentiation in Acute Myeloid Leukemia.
    Maiques-Diaz A; Spencer GJ; Lynch JT; Ciceri F; Williams EL; Amaral FMR; Wiseman DH; Harris WJ; Li Y; Sahoo S; Hitchin JR; Mould DP; Fairweather EE; Waszkowycz B; Jordan AM; Smith DL; Somervaille TCP
    Cell Rep; 2018 Mar; 22(13):3641-3659. PubMed ID: 29590629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMG20B stabilizes association of LSD1 with GFI1 on chromatin to confer transcription repression and leukemia cell differentiation block.
    Maiques-Diaz A; Nicosia L; Basma NJ; Romero-Camarero I; Camera F; Spencer GJ; Amaral FMR; Simeoni F; Wingelhofer B; Williamson AJK; Pierce A; Whetton AD; Somervaille TCP
    Oncogene; 2022 Oct; 41(44):4841-4854. PubMed ID: 36171271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-495 is a Predictive Biomarker that Downregulates GFI1 Expression in Medulloblastoma.
    Wang C; Yun Z; Zhao T; Liu X; Ma X
    Cell Physiol Biochem; 2015; 36(4):1430-9. PubMed ID: 26160036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nascent transcript and single-cell RNA-seq analysis defines the mechanism of action of the LSD1 inhibitor INCB059872 in myeloid leukemia.
    Johnston G; Ramsey HE; Liu Q; Wang J; Stengel KR; Sampathi S; Acharya P; Arrate M; Stubbs MC; Burn T; Savona MR; Hiebert SW
    Gene; 2020 Aug; 752():144758. PubMed ID: 32422235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LSD1-mediated repression of GFI1 super-enhancer plays an essential role in erythroleukemia.
    Tatsumi G; Kawahara M; Yamamoto R; Hishizawa M; Kito K; Suzuki T; Takaori-Kondo A; Andoh A
    Leukemia; 2020 Mar; 34(3):746-758. PubMed ID: 31676828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone demethylase UTX/KDM6A enhances tumor immune cell recruitment, promotes differentiation and suppresses medulloblastoma.
    Yi J; Shi X; Xuan Z; Wu J
    Cancer Lett; 2021 Feb; 499():188-200. PubMed ID: 33253789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GFI1 functions in transcriptional control and cell fate determination require SNAG domain methylation to recruit LSD1.
    Velinder M; Singer J; Bareyan D; Meznarich J; Tracy CM; Fulcher JM; McClellan D; Lucente H; Franklin S; Sharma S; Engel ME
    Biochem J; 2016 Oct; 473(19):3355-69. PubMed ID: 27480105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth factor independence 1 (Gfi1) as a regulator of p53 activity and a new therapeutical target for ALL.
    Khandanpour C; Möröy T
    Oncotarget; 2013 Mar; 4(3):374-5. PubMed ID: 23528269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMOylation Regulates Growth Factor Independence 1 in Transcriptional Control and Hematopoiesis.
    Andrade D; Velinder M; Singer J; Maese L; Bareyan D; Nguyen H; Chandrasekharan MB; Lucente H; McClellan D; Jones D; Sharma S; Liu F; Engel ME
    Mol Cell Biol; 2016 May; 36(10):1438-50. PubMed ID: 26951200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gfi1, a transcriptional repressor, inhibits the induction of the T helper type 1 programme in activated CD4 T cells.
    Suzuki J; Maruyama S; Tamauchi H; Kuwahara M; Horiuchi M; Mizuki M; Ochi M; Sawasaki T; Zhu J; Yasukawa M; Yamashita M
    Immunology; 2016 Apr; 147(4):476-87. PubMed ID: 26749286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GFI1 proteins orchestrate the emergence of haematopoietic stem cells through recruitment of LSD1.
    Thambyrajah R; Mazan M; Patel R; Moignard V; Stefanska M; Marinopoulou E; Li Y; Lancrin C; Clapes T; Möröy T; Robin C; Miller C; Cowley S; Göttgens B; Kouskoff V; Lacaud G
    Nat Cell Biol; 2016 Jan; 18(1):21-32. PubMed ID: 26619147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation.
    He Y; Zhao Y; Wang L; Bohrer LR; Pan Y; Wang L; Huang H
    Oncogene; 2018 Jan; 37(4):534-543. PubMed ID: 28991226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LSD1 promotes the egress of hematopoietic stem and progenitor cells into the bloodstream during the endothelial-to-hematopoietic transition.
    Tamaoki J; Maeda H; Kobayashi I; Takeuchi M; Ohashi K; Gore A; Bonkhofer F; Patient R; Weinstein BM; Kobayashi M
    Dev Biol; 2023 Sep; 501():92-103. PubMed ID: 37353106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological inhibition of LSD1 activity blocks REST-dependent medulloblastoma cell migration.
    Callegari K; Maegawa S; Bravo-Alegria J; Gopalakrishnan V
    Cell Commun Signal; 2018 Sep; 16(1):60. PubMed ID: 30227871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth.
    Binning MJ; Niazi T; Pedone CA; Lal B; Eberhart CG; Kim KJ; Laterra J; Fults DW
    Cancer Res; 2008 Oct; 68(19):7838-45. PubMed ID: 18829539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redefining the molecular substructure of medulloblastoma.
    Benmaamar R
    Lancet Oncol; 2017 Sep; 18(9):e514. PubMed ID: 28757377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.